The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Trading Update

30 Jan 2017 07:00

RNS Number : 4157V
HydroDec Group plc
30 January 2017
 

30 January 2017

 

Hydrodec Group plc

("Hydrodec", the "Company" or the "Group")

 

Pre-close Trading Update

 

Hydrodec Group plc (AIM: HYR), the cleantech industrial oil re-refining group, is pleased to provide a trading update for the financial year ended 31 December 2016.

 

Unuadited highlights for year ended 31 December 2016

· Revenues from continuing core re-refining business expected to increase by approximately 100% to US$16.4 million (2015: US$8.2 million), reflecting the full recommissioning of the Canton plant at the end of 2015

· Increased Group sales volumes of premium quality SUPERFINE transformer oil and base oil for the year of 33.3 million litres (2015: 14.4 million litres), up 130%

· Continued improvement of plant operability, with an average utilisation rate of 73% achieved for the year, further validated by significantly lower number of production hours lost through unscheduled stoppages

· Gross unit margins higher than 2015, despite lower product sales prices and challenging market conditions

· Improved sales mix between higher margin transformer oil and lower margin base oil, with transformer oil sales representing 57% of total Group oil sales in 2016, up from 7% in 2015

 

· Significant reduction in corporate costs already realised with benefits from more recently implemented initiatives continuing to filter through into 2017

· Group EBITDA loss from continuing operations significantly reduced in the year and expected to be marginally above market expectations. Group EBITDA expected to be positive for Q4 2016, despite the usual seasonal trends, providing the Company with confidence that this trend towards positive EBITDA at Group level will continue in 2017

· Carbon credit approval enabling Hydrodec's product to be sold with a carbon offset and creating a future incremental revenue stream

· SUPERFINE transformer oil in the US achieved "500 hour" quality status

· Additional investment by G&S Technologies Group in Hydrodec of North America in October 2016

· Disposal of loss-making UK recycling operations in March 2016

 

Outlook

 

This update confirms significant progress in the turnaround of the Company over the past twelve months. Whilst the general operating environment for oil related businesses has improved recently, positively impacting the Group's pricing and margins, challenges still remain. 2017 has begun strongly in terms of sales orders in the US and Australia. Whilst the Australian feedstock position remains robust, the feedstock position in the US is tighter. Higher margin transformer oil sales currently represent c. 60% of total Group oil sales, with scope for further improvement through the year.

 

In 2017, the Group remains focused on continued progress from its positive Q4 2016 performance, which will be driven by strengthening margins as the Group continues to grow market share and deliver further cost reductions and efficiencies where appropriate. This should enable Hydrodec to deliver positive Group EBITDA for 2017 as a whole.

 

Chris Ellis, Chief Executive Officer of Hydrodec, commented: "I am pleased to report a move into positive Group EBITDA in the last quarter of 2016, as much of our recent hard work begins to pay dividends in terms of Canton's strong operational performance, our increasing penetration of the transformer oil market, and the impact of cost cutting measures over central corporate expenditure. Despite continuing challenges in a still volatile market, I am confident that 2017 will see a move for the Group towards full year positive EBITDA and look forward to reporting further progress."

 

For further information, please contact:

 

Hydrodec Group plc

 

01372 824750

Chris Ellis, Chief Executive

 

 

 

Canaccord Genuity (Nominated Adviser and Broker)

 

020 7523 8000

Henry Fitzgerald-O'Connor

Richard Andrews

 

 

 

Vigo Communications (PR adviser to Hydrodec)

 

020 7830 9700

Patrick d'Ancona

Chris McMahon

 

 

Notes to Editors:

Hydrodec's technology is a proven, highly efficient, oil re-refining and chemical process initially targeted at the multi-billion US$ market for transformer oil used by the world's electricity industry. MarketsandMarkets forecasts that the global transformer oil market is expected to grow from US$1.98 billion in 2015 to US$2.79 billion by 2020 at a CAGR of 7.14% from 2015 to 2020. Spent oil is currently processed at two commercial plants with distinct competitive advantage delivered through very high recoveries (near 100%), producing 'as new' high quality oils at competitive cost and without environmentally harmful emissions. The process also completely eliminates PCBs, a toxic additive banned under international regulations. Hydrodec's plants are located at Canton, Ohio, US and Bomen, New South Wales, Australia. 

 

Hydrodec's shares are listed on the AIM Market of the London Stock Exchange. For further information, please visit www.hydrodec.com.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKCDBBBKBODB
Date   Source Headline
2nd Nov 20127:00 amRNSConvertible Unsecured Loan Stock
31st Oct 20123:37 pmRNSDirector's dealing in securities
31st Oct 20127:00 amRNSDirector's dealing in securities
25th Oct 20127:00 amRNSDirector's dealing in securities
24th Oct 20127:00 amRNSAppointment of Chairman
12th Sep 201210:50 amRNSNotification of Interest
6th Sep 20127:00 amRNSInterim Results
16th Aug 201211:13 amRNSNotification of Interim Results
9th Aug 20122:07 pmRNSDirectorate Change
6th Aug 201210:35 amRNSJoint marketing agreement
3rd Jul 20127:00 amRNSDirector's dealing
27th Jun 20122:37 pmRNSUS approves treatment of PCB-contaminated oil
25th Jun 201212:00 pmRNSResult of AGM
25th Jun 20127:00 amRNSAGM Statement
15th Jun 20127:00 amRNSContract Win
8th Jun 20121:03 pmRNSAppointment of Chief Financial Officer
22nd May 20124:17 pmRNSNotification of interest
4th May 201212:36 pmRNSDirector's Dealing
25th Apr 20124:15 pmRNSEPA issues draft approval
19th Apr 20127:00 amRNSFinal Results
3rd Apr 20127:00 amRNSNotice of Results
13th Mar 201211:53 amRNSChange of Registered Office
17th Feb 20123:44 pmRNSDirector Dealing
1st Feb 20122:25 pmRNSDirector's Dealing
30th Jan 20121:12 pmRNSDirectorate Change
25th Jan 20129:14 amRNSDirector's dealing
18th Jan 20125:35 pmRNSDirector's Dealing
17th Jan 20123:24 pmRNSDirector's dealing
16th Jan 20127:00 amRNSTrading Update
7th Dec 20117:00 amRNSAppointments
28th Nov 20113:30 pmRNSNotification of Interest
28th Nov 201112:15 pmRNSNotification of Interest
28th Nov 201111:43 amRNSTotal Voting Rights
21st Nov 201110:46 amRNSResult of General Meeting
3rd Nov 20113:15 pmRNSPosting of Circular
2nd Nov 20117:00 amRNSAppointment of CEO and Placing
31st Oct 20114:17 pmRNSRe press speculation
26th Sep 201111:26 amRNSDirector's dealing - Replacement
26th Sep 20117:00 amRNSDirector's dealing
21st Sep 20117:00 amRNSInterim Results
26th Aug 20113:00 pmRNSDirector change in information
12th Jul 20117:00 amRNSDirector's dealing
11th Jul 201111:28 amRNSSigning of first operating joint venture in Japan
23rd Jun 20117:00 amRNSDirectorate Change
9th Jun 201111:51 amRNSResult of AGM
9th Jun 20117:00 amRNSAGM Statement
8th Jun 20118:38 amRNSNotification of Interest
25th May 201110:01 amRNS£2 million debt financing to fund growth
17th May 201112:33 pmRNSAnnual Report & Notice of AGM
26th Apr 20115:17 pmRNSNotification of Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.